Noel Donnelly is now serving in a new position at EIP Pharma, Inc.

Aug 06, 2019
Board and Executive Moves
Background Information
Chief Financial Officer at EIP Pharma, Inc.
EIP Pharma, Inc. engages in the research and development of therapeutic drugs for the central nervous system disorders. It focuses on neflamapimod, which is a clinical-stage oral investigational drug for the treatment of brain diseases such as Alzheimer's disease and for non-brain disorders including rheumatoid arthritis. The company was founded by John Alam and Sylvie Louise Gregorie and is headquartered in Cambridge, MA.